9955 — ClouDr Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapValue Trap

Annual income statement for ClouDr, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	839	1,757	2,988	3,691	3,488
Cost of Revenue
Gross Profit	233	570	792	909	862
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	1,676	2,453	3,585	4,005	3,948
Operating Profit	-837	-696	-597	-314	-460
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-2,898	-4,156	-1,694	-327	-489
Provision for Income Taxes
Net Income After Taxes	-2,897	-4,153	-1,692	-327	-491
Minority Interest
Net Income Before Extraordinary Items
Net Income	-2,867	-4,139	-1,689	-323	-516
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-2,867	-4,139	-1,689	-323	-516
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-4.88	-7.01	-5.61	-0.597	-0.797